Bachem Holding AG

Swiss public CDMO (BANB.SW). Founded 1971, headquartered in Bubendorf, Switzerland. Operates 6 GMP facilities across Switzerland, USA, and UK. Produces peptides and oligonucleotides for pharma/biotech. Leading supplier of commercial peptide APIs. Offers global door-to-door logistics for research and commercial clients.

Bachem Holding AG is listed as a CDMO in the peptide supply chain, serving Global markets from Switzerland / USA. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 3 independent sources, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.